August 28th, 2014
Predicting PARADIGM-HF, or What to Expect When You’re Expecting
Larry Husten, PHD
Larry Husten analyzes the expectations surrounding the upcoming release of PARADIGM-HF and its centerpiece LCZ696 from the perspective of the medical field as well as the world of economics.
August 18th, 2014
Selections from Richard Lehman’s Literature Review: August 18th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include the three sodium studies from NEJM, the CLARIFY study, and more.
August 14th, 2014
The CardioMEMS HF System: What Do You Say to Your Patient?
John Ryan, MD
In this scenario based on a patient’s question about the CardioMEMS device, John Ryan asks, “What do you say to your patient?”
August 7th, 2014
How Should We Evaluate Hospital Care?
Xiao Xu, PhD
Dr. Xiao Xu weighs in on the question of how we should quantify the cost-effectiveness of hospital care.
July 29th, 2014
Cardiac Rehab for Heart Failure Patients: The CMS Is Convinced — Are You?
Ileana Piña, MD, MPH and John Ryan, MD
John Ryan interviews Dr. Ileana Piña about her work in HF-ACTION as it relates to the CMS’s recent expansion of cardiac rehabilitation coverage.
June 16th, 2014
Selections from Richard Lehman’s Literature Review: June 16th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include statins and physical activity in older men, transitional care interventions to prevent heart-failure readmissions, and more.
April 14th, 2014
Selections from Richard Lehman’s Literature Review: April 14th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include TOPCAT, fibrinolysis for those with intermediate-risk PE, and more.
April 9th, 2014
Putting TOPCAT in Perspective
Bertram Pitt, MD, Marc A. Pfeffer, MD and Clyde Yancy, MD
TOPCAT investigators Bertram Pitt and Marc Pfeffer discuss the trial, and Clyde Yancy offers his analysis.
April 7th, 2014
Selections from Richard Lehman’s Literature Review: April 7th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include SYMPLICITY HTN-3, CoreValve, MADIT-CRT, and more.
March 30th, 2014
Long-Term Follow-Up from MADIT-CRT: Guideline Implications
Arthur J. Moss, MD
Arthur J. Moss discusses his research group’s study of long-term survival for patients who received cardiac resynchronization therapy with a defibrillator in the MADIT-CRT trial.
NEJM Journal Watch — Recent Cardiology Articles- Sex-Based Disparity in CABG Outcomes: Are We Moving Toward Parity?
- Can Genetic and Social Risk Scores Improve Cardiac Risk Prediction?
- Extensive Ablation vs. Pulmonary Vein Isolation in Persistent Atrial Fibrillation
- Can a Novel Stent Design Improve Long-Term Outcomes of Percutaneous Coronary Intervention?
- Are Angiographically-Derived Coronary Physiology Measurements Ready for Use in the Cath Lab?